Medicine made from human antibodies help us battle cancer and other diseases — but they blend into our immune system so well, it's difficult to track their side effects. Shark antibodies, by contrast, stand out like a sore thumb. Antibody researcher Doreen Koenning has dedicated her career to studying how these proteins could become a valuable tool in clinical drug trials — and potentially create a new breed of treatment in the fight against cancer.
